USA Vitamin B2 Prices Climbs Up 0.5% Amid Steady Demand from Health Care Sector

USA Vitamin B2 Prices Climbs Up 0.5% Amid Steady Demand from Health Care Sector

Phoebe Cary 28-Nov-2025

The suppliers of Vitamin B2 in the US have increased the market value by margins to safeguard the client relationships in November 2025. The upward trend in the prices of Vitamin B2 was the result of unwavering demand from the downstream sectors like pharmaceuticals and personal care. The end-users have kept stable offtake of immune supplements and vitamin formulations. The buyers were actively managing their inventories and tried to balance the stocks left from previous production cycles with the new ones. The demand from the end-users have shifted as winter approached which prompted the suppliers to adopt competitive yet marginally higher prices to prevent sourcing diversification. The dynamic interplay of inventory management and strategic prices has resulted in a marginal increase in Vitamin B2 prices for November 2025. The increase has reflected a market where supply chains were finely tuned that met evolved consumer needs without abrupt disruptions. The stakeholders can turn potential price increase into opportunities for sustained growth by aligning their strategies with the demand forecasts.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Vitamin B2

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.